

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of B cell differentiation (GO:0045579) | 6.03392363 |
| 2 | immunoglobulin mediated immune response (GO:0016064) | 5.74065296 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.70185545 |
| 4 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.73158807 |
| 5 | B cell mediated immunity (GO:0019724) | 4.69128835 |
| 6 | positive T cell selection (GO:0043368) | 4.64950740 |
| 7 | negative thymic T cell selection (GO:0045060) | 4.55825706 |
| 8 | positive thymic T cell selection (GO:0045059) | 4.54616380 |
| 9 | negative T cell selection (GO:0043383) | 4.44324606 |
| 10 | positive regulation of tolerance induction (GO:0002645) | 4.30952705 |
| 11 | regulation of T cell tolerance induction (GO:0002664) | 4.28440678 |
| 12 | regulation of regulatory T cell differentiation (GO:0045589) | 4.26322519 |
| 13 | regulation of B cell differentiation (GO:0045577) | 4.18814462 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.15333903 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.10602334 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.01996580 |
| 17 | actin nucleation (GO:0045010) | 4.01098758 |
| 18 | regulation of tolerance induction (GO:0002643) | 3.97987408 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 3.94236078 |
| 20 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.92105242 |
| 21 | defense response to protozoan (GO:0042832) | 3.80320460 |
| 22 | histamine secretion (GO:0001821) | 3.79095017 |
| 23 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.78722253 |
| 24 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.76387044 |
| 25 | leukocyte aggregation (GO:0070486) | 3.74067360 |
| 26 | T cell selection (GO:0045058) | 3.73472263 |
| 27 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.73397205 |
| 28 | autophagic vacuole fusion (GO:0000046) | 3.72699014 |
| 29 | DNA deamination (GO:0045006) | 3.70583927 |
| 30 | response to peptidoglycan (GO:0032494) | 3.70421261 |
| 31 | response to protozoan (GO:0001562) | 3.64210720 |
| 32 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.60379860 |
| 33 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.60258890 |
| 34 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.57435865 |
| 35 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.57435865 |
| 36 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.55285065 |
| 37 | positive regulation of lamellipodium assembly (GO:0010592) | 3.54538538 |
| 38 | thymic T cell selection (GO:0045061) | 3.53360718 |
| 39 | T cell costimulation (GO:0031295) | 3.53259744 |
| 40 | regulation of germinal center formation (GO:0002634) | 3.52393848 |
| 41 | lymphocyte costimulation (GO:0031294) | 3.48366066 |
| 42 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.42356517 |
| 43 | positive regulation of type 2 immune response (GO:0002830) | 3.41876793 |
| 44 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.40810778 |
| 45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.37280022 |
| 46 | DNA synthesis involved in DNA repair (GO:0000731) | 3.36394732 |
| 47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.36073827 |
| 48 | cytidine deamination (GO:0009972) | 3.34538121 |
| 49 | cytidine metabolic process (GO:0046087) | 3.34538121 |
| 50 | cytidine catabolic process (GO:0006216) | 3.34538121 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.33976246 |
| 52 | response to host immune response (GO:0052572) | 3.33046976 |
| 53 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.33046976 |
| 54 | cellular extravasation (GO:0045123) | 3.28842528 |
| 55 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.28529491 |
| 56 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.28020768 |
| 57 | positive regulation of mast cell activation (GO:0033005) | 3.26580974 |
| 58 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.22201063 |
| 59 | negative regulation of B cell apoptotic process (GO:0002903) | 3.19947458 |
| 60 | negative regulation of type 2 immune response (GO:0002829) | 3.19351390 |
| 61 | positive regulation of mast cell degranulation (GO:0043306) | 3.14794819 |
| 62 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.14794819 |
| 63 | neutrophil mediated immunity (GO:0002446) | 3.12103445 |
| 64 | regulation of type 2 immune response (GO:0002828) | 3.11131505 |
| 65 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.09623100 |
| 66 | modulation by symbiont of host immune response (GO:0052553) | 3.09623100 |
| 67 | positive regulation by symbiont of host defense response (GO:0052509) | 3.09623100 |
| 68 | modulation by symbiont of host defense response (GO:0052031) | 3.09623100 |
| 69 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.09623100 |
| 70 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.09623100 |
| 71 | neutrophil activation (GO:0042119) | 3.06895715 |
| 72 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.06041569 |
| 73 | regulation of antigen processing and presentation (GO:0002577) | 3.04732461 |
| 74 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.02824791 |
| 75 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.98723752 |
| 76 | organelle membrane fusion (GO:0090174) | 2.97636378 |
| 77 | T cell receptor signaling pathway (GO:0050852) | 2.97310449 |
| 78 | microglial cell activation (GO:0001774) | 2.96093225 |
| 79 | response to host (GO:0075136) | 2.95119766 |
| 80 | response to host defenses (GO:0052200) | 2.95119766 |
| 81 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.95119766 |
| 82 | positive regulation of B cell activation (GO:0050871) | 2.94791689 |
| 83 | regulation of B cell apoptotic process (GO:0002902) | 2.94236442 |
| 84 | mature B cell differentiation involved in immune response (GO:0002313) | 2.93196169 |
| 85 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.91700547 |
| 86 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.91647451 |
| 87 | positive regulation of neutrophil migration (GO:1902624) | 2.91647451 |
| 88 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.90099036 |
| 89 | positive regulation of lymphocyte differentiation (GO:0045621) | 2.89351890 |
| 90 | respiratory burst (GO:0045730) | 2.86839717 |
| 91 | positive regulation of interleukin-4 production (GO:0032753) | 2.86161947 |
| 92 | histamine transport (GO:0051608) | 2.85983657 |
| 93 | positive regulation of defense response to virus by host (GO:0002230) | 2.85501960 |
| 94 | negative regulation of T cell apoptotic process (GO:0070233) | 2.84954252 |
| 95 | granulocyte activation (GO:0036230) | 2.82471491 |
| 96 | negative regulation of interleukin-17 production (GO:0032700) | 2.80724368 |
| 97 | production of molecular mediator of immune response (GO:0002440) | 2.80654950 |
| 98 | positive regulation of isotype switching (GO:0045830) | 2.80334462 |
| 99 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.79719476 |
| 100 | regulation of hypersensitivity (GO:0002883) | 2.76893706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.03456683 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.76966689 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.42079881 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.66414229 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.33460870 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28888253 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.20260912 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.15725359 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.04460583 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.91181051 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.75752947 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.74841073 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.72964390 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61768953 |
| 15 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.61240309 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.39331075 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.34616059 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.31651465 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.30649299 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.30391948 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29260049 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.27575215 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19007395 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.16355703 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10971154 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 2.09233671 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.06019081 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.03966801 |
| 29 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.03538888 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 1.97126778 |
| 31 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.94724272 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.94662282 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.86563940 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.84327460 |
| 35 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.82145633 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78257076 |
| 37 | GATA3_26560356_Chip-Seq_TH2_Human | 1.68597848 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67123394 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60632191 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.57951061 |
| 41 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57801921 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57708063 |
| 43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.52925770 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.50237756 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48647835 |
| 46 | MYC_22102868_ChIP-Seq_BL_Human | 1.48481532 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48366561 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45784383 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.45148221 |
| 50 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.44074694 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41669425 |
| 52 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.41303754 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41080398 |
| 54 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.39797065 |
| 55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.35809986 |
| 56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35055275 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33113405 |
| 58 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30458192 |
| 59 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23614558 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23559720 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19741575 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13424881 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13148389 |
| 64 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12381375 |
| 65 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.12347789 |
| 66 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.11843302 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11170557 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10482541 |
| 69 | P300_27268052_Chip-Seq_Bcells_Human | 1.09361332 |
| 70 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.07496642 |
| 71 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07238295 |
| 72 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.06913526 |
| 73 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.05874742 |
| 74 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03777479 |
| 75 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.03627088 |
| 76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02924774 |
| 77 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.02899420 |
| 78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02367365 |
| 79 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02287854 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01619348 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01287128 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98181207 |
| 83 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97472060 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97340894 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96124132 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96123751 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95145526 |
| 88 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.94941991 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94385487 |
| 90 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93841533 |
| 91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93753147 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91746166 |
| 93 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89916013 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89537866 |
| 95 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.87890080 |
| 96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87442076 |
| 97 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87114797 |
| 98 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.84668035 |
| 99 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.84424346 |
| 100 | VDR_22108803_ChIP-Seq_LS180_Human | 0.84305009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.68743245 |
| 2 | MP0005671_abnormal_response_to | 4.03137932 |
| 3 | MP0003436_decreased_susceptibility_to | 3.19991010 |
| 4 | MP0001873_stomach_inflammation | 3.16600463 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.03288242 |
| 6 | MP0003724_increased_susceptibility_to | 2.94975214 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.94742740 |
| 8 | MP0000465_gastrointestinal_hemorrhage | 2.92029267 |
| 9 | MP0001800_abnormal_humoral_immune | 2.82954469 |
| 10 | MP0009785_altered_susceptibility_to | 2.75125393 |
| 11 | MP0005025_abnormal_response_to | 2.59690543 |
| 12 | MP0002723_abnormal_immune_serum | 2.54985806 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.49703185 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.48159543 |
| 15 | MP0001819_abnormal_immune_cell | 2.44358001 |
| 16 | MP0002419_abnormal_innate_immunity | 2.40714605 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.39444178 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.38625973 |
| 19 | MP0002405_respiratory_system_inflammati | 2.14315044 |
| 20 | MP0001790_abnormal_immune_system | 2.10561586 |
| 21 | MP0005387_immune_system_phenotype | 2.10561586 |
| 22 | MP0003763_abnormal_thymus_physiology | 2.09705640 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.09074859 |
| 24 | MP0000685_abnormal_immune_system | 2.06542833 |
| 25 | MP0006082_CNS_inflammation | 2.05436239 |
| 26 | MP0009764_decreased_sensitivity_to | 2.04985265 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.02529243 |
| 28 | MP0005084_abnormal_gallbladder_morpholo | 2.00736629 |
| 29 | MP0002398_abnormal_bone_marrow | 1.96334749 |
| 30 | MP0001853_heart_inflammation | 1.93471341 |
| 31 | MP0000716_abnormal_immune_system | 1.85798416 |
| 32 | MP0003303_peritoneal_inflammation | 1.83490530 |
| 33 | MP0002006_tumorigenesis | 1.81134012 |
| 34 | MP0002009_preneoplasia | 1.75861650 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.68063708 |
| 36 | MP0009278_abnormal_bone_marrow | 1.64754231 |
| 37 | MP0008995_early_reproductive_senescence | 1.62563841 |
| 38 | MP0002722_abnormal_immune_system | 1.56433083 |
| 39 | MP0002429_abnormal_blood_cell | 1.54244520 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.53838009 |
| 41 | MP0004947_skin_inflammation | 1.49587803 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.46168054 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.44904672 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.44904672 |
| 45 | MP0003075_altered_response_to | 1.43348680 |
| 46 | MP0008058_abnormal_DNA_repair | 1.43039906 |
| 47 | MP0000858_altered_metastatic_potential | 1.40495812 |
| 48 | MP0008469_abnormal_protein_level | 1.39357074 |
| 49 | MP0009697_abnormal_copulation | 1.39283936 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.36775349 |
| 51 | MP0008260_abnormal_autophagy | 1.34624109 |
| 52 | MP0003866_abnormal_defecation | 1.32126557 |
| 53 | MP0009763_increased_sensitivity_to | 1.26880259 |
| 54 | MP0002132_abnormal_respiratory_system | 1.26160780 |
| 55 | MP0008877_abnormal_DNA_methylation | 1.18470383 |
| 56 | MP0008004_abnormal_stomach_pH | 1.16954833 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.15684716 |
| 58 | MP0001851_eye_inflammation | 1.11027850 |
| 59 | MP0005166_decreased_susceptibility_to | 1.10653102 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.07571640 |
| 61 | MP0002933_joint_inflammation | 1.06645551 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.04930603 |
| 63 | MP0005451_abnormal_body_composition | 1.04425224 |
| 64 | MP0002822_catalepsy | 1.02919652 |
| 65 | MP0001663_abnormal_digestive_system | 1.02706178 |
| 66 | MP0005310_abnormal_salivary_gland | 0.97652269 |
| 67 | MP0002396_abnormal_hematopoietic_system | 0.96657698 |
| 68 | MP0008961_abnormal_basal_metabolism | 0.96592020 |
| 69 | MP0005535_abnormal_body_temperature | 0.95281922 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 0.94537800 |
| 71 | MP0005075_abnormal_melanosome_morpholog | 0.94400007 |
| 72 | MP0009765_abnormal_xenobiotic_induced | 0.91788311 |
| 73 | MP0002019_abnormal_tumor_incidence | 0.90683508 |
| 74 | MP0002735_abnormal_chemical_nociception | 0.90235417 |
| 75 | MP0002653_abnormal_ependyma_morphology | 0.86151489 |
| 76 | MP0004883_abnormal_blood_vessel | 0.84560983 |
| 77 | MP0000249_abnormal_blood_vessel | 0.83352053 |
| 78 | MP0009840_abnormal_foam_cell | 0.76017951 |
| 79 | MP0002102_abnormal_ear_morphology | 0.74946300 |
| 80 | MP0005647_abnormal_sex_gland | 0.73308071 |
| 81 | MP0002693_abnormal_pancreas_physiology | 0.72582118 |
| 82 | MP0005164_abnormal_response_to | 0.70786838 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 0.70397712 |
| 84 | MP0003828_pulmonary_edema | 0.70332224 |
| 85 | MP0005381_digestive/alimentary_phenotyp | 0.65734095 |
| 86 | MP0003638_abnormal_response/metabolism_ | 0.64874259 |
| 87 | MP0003786_premature_aging | 0.60408768 |
| 88 | MP0001986_abnormal_taste_sensitivity | 0.59009373 |
| 89 | MP0005220_abnormal_exocrine_pancreas | 0.56420810 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.54377881 |
| 91 | MP0003448_altered_tumor_morphology | 0.54135972 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.51711232 |
| 93 | MP0009115_abnormal_fat_cell | 0.50677204 |
| 94 | MP0006036_abnormal_mitochondrial_physio | 0.49963928 |
| 95 | MP0008874_decreased_physiological_sensi | 0.48947702 |
| 96 | MP0004043_abnormal_pH_regulation | 0.48465320 |
| 97 | MP0000681_abnormal_thyroid_gland | 0.47810867 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.47041747 |
| 99 | MP0005165_increased_susceptibility_to | 0.45640768 |
| 100 | MP0002733_abnormal_thermal_nociception | 0.45436341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.11483963 |
| 2 | Chronic obstructive pulmonary disease (HP:0006510) | 4.89326719 |
| 3 | Obstructive lung disease (HP:0006536) | 4.89326719 |
| 4 | Abnormality of the prostate (HP:0008775) | 4.46175695 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.38624849 |
| 6 | Autoimmune hemolytic anemia (HP:0001890) | 4.30761173 |
| 7 | Myositis (HP:0100614) | 4.07926042 |
| 8 | Aplastic anemia (HP:0001915) | 4.02951083 |
| 9 | Meningitis (HP:0001287) | 3.93363039 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.78542373 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.78401283 |
| 12 | Hemoptysis (HP:0002105) | 3.68510016 |
| 13 | Agammaglobulinemia (HP:0004432) | 3.57173791 |
| 14 | Stomatitis (HP:0010280) | 3.51979480 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.51132871 |
| 16 | Encephalitis (HP:0002383) | 3.50955074 |
| 17 | Petechiae (HP:0000967) | 3.49995420 |
| 18 | Panhypogammaglobulinemia (HP:0003139) | 3.40607659 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.37902728 |
| 20 | Pulmonary infiltrates (HP:0002113) | 3.32929877 |
| 21 | Chest pain (HP:0100749) | 3.32750974 |
| 22 | Eczematoid dermatitis (HP:0000976) | 3.28212221 |
| 23 | Epistaxis (HP:0000421) | 3.27149634 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.25354821 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.25354821 |
| 26 | Prolonged bleeding time (HP:0003010) | 3.16609930 |
| 27 | Recurrent skin infections (HP:0001581) | 3.10989791 |
| 28 | Optic neuritis (HP:0100653) | 3.09187643 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 3.09187643 |
| 30 | Vasculitis (HP:0002633) | 3.08171006 |
| 31 | Orchitis (HP:0100796) | 3.01437630 |
| 32 | Abnormality of B cell number (HP:0010975) | 2.99083737 |
| 33 | Gangrene (HP:0100758) | 2.98286582 |
| 34 | Abnormality of male internal genitalia (HP:0000022) | 2.87890815 |
| 35 | Recurrent viral infections (HP:0004429) | 2.82436476 |
| 36 | Purpura (HP:0000979) | 2.81226108 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 2.80624023 |
| 38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.77438595 |
| 39 | Gingival bleeding (HP:0000225) | 2.76169894 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.70215212 |
| 41 | Mediastinal lymphadenopathy (HP:0100721) | 2.68089765 |
| 42 | Decreased central vision (HP:0007663) | 2.67539026 |
| 43 | Increased IgM level (HP:0003496) | 2.67083021 |
| 44 | Increased intramyocellular lipid droplets (HP:0012240) | 2.66628940 |
| 45 | Skin rash (HP:0000988) | 2.65724898 |
| 46 | Gastrointestinal inflammation (HP:0004386) | 2.65176425 |
| 47 | Alveolar cell carcinoma (HP:0006519) | 2.63435374 |
| 48 | Leukocytosis (HP:0001974) | 2.61050448 |
| 49 | Cerebral palsy (HP:0100021) | 2.60180853 |
| 50 | Increased cerebral lipofuscin (HP:0011813) | 2.58229960 |
| 51 | Glomerulopathy (HP:0100820) | 2.56886948 |
| 52 | Abnormality of the pleura (HP:0002103) | 2.56483821 |
| 53 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.55661919 |
| 54 | Eosinophilia (HP:0001880) | 2.55191054 |
| 55 | Hypertensive crisis (HP:0100735) | 2.54329429 |
| 56 | Granulocytopenia (HP:0001913) | 2.53418436 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 2.52884315 |
| 58 | B lymphocytopenia (HP:0010976) | 2.52756178 |
| 59 | Increased IgE level (HP:0003212) | 2.51811415 |
| 60 | Hypergammaglobulinemia (HP:0010702) | 2.49300709 |
| 61 | Severe combined immunodeficiency (HP:0004430) | 2.44681052 |
| 62 | Amyotrophic lateral sclerosis (HP:0007354) | 2.40296732 |
| 63 | Inflammation of the large intestine (HP:0002037) | 2.40259838 |
| 64 | IgG deficiency (HP:0004315) | 2.38911726 |
| 65 | Chronic otitis media (HP:0000389) | 2.38661539 |
| 66 | Urticaria (HP:0001025) | 2.37914660 |
| 67 | Pulmonary fibrosis (HP:0002206) | 2.37291676 |
| 68 | Thrombocytosis (HP:0001894) | 2.33966270 |
| 69 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.32347736 |
| 70 | IgM deficiency (HP:0002850) | 2.29988784 |
| 71 | Abnormality of T cell number (HP:0011839) | 2.29804785 |
| 72 | Visual hallucinations (HP:0002367) | 2.27115392 |
| 73 | Ureteral stenosis (HP:0000071) | 2.25109636 |
| 74 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.24082851 |
| 75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.24082851 |
| 76 | Abnormality of glycolipid metabolism (HP:0010969) | 2.24082851 |
| 77 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.23149186 |
| 78 | Abnormality of the pericardium (HP:0001697) | 2.22578310 |
| 79 | T lymphocytopenia (HP:0005403) | 2.19981218 |
| 80 | Recurrent bronchitis (HP:0002837) | 2.18257717 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 2.15649164 |
| 82 | Abnormality of T cells (HP:0002843) | 2.14984517 |
| 83 | Abnormal platelet volume (HP:0011876) | 2.12030279 |
| 84 | Amyloidosis (HP:0011034) | 2.11436967 |
| 85 | Polyneuropathy (HP:0001271) | 2.10880103 |
| 86 | Acute lymphatic leukemia (HP:0006721) | 2.10569777 |
| 87 | Abnormality of eosinophils (HP:0001879) | 2.09673882 |
| 88 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.09350504 |
| 89 | Increased muscle lipid content (HP:0009058) | 2.06636428 |
| 90 | Pulmonary embolism (HP:0002204) | 2.06626190 |
| 91 | Myopathic facies (HP:0002058) | 2.05862576 |
| 92 | Ureteral obstruction (HP:0006000) | 2.04542352 |
| 93 | Keratoconjunctivitis (HP:0001096) | 2.03878145 |
| 94 | Arterial thrombosis (HP:0004420) | 1.99279727 |
| 95 | Cellulitis (HP:0100658) | 1.98846342 |
| 96 | Osteomyelitis (HP:0002754) | 1.98299620 |
| 97 | Combined immunodeficiency (HP:0005387) | 1.95727426 |
| 98 | Facial diplegia (HP:0001349) | 1.93708515 |
| 99 | Episodic fever (HP:0001954) | 1.89997866 |
| 100 | Microretrognathia (HP:0000308) | 1.89679588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.18544583 |
| 2 | TXK | 4.08488676 |
| 3 | MAP4K1 | 3.34259801 |
| 4 | AKT3 | 3.27166255 |
| 5 | KDR | 3.16885597 |
| 6 | FES | 2.72778449 |
| 7 | RIPK4 | 2.44396228 |
| 8 | TESK2 | 2.40151096 |
| 9 | TBK1 | 2.16823183 |
| 10 | SYK | 2.04828587 |
| 11 | MAP3K6 | 2.03055273 |
| 12 | PIK3CG | 2.00271733 |
| 13 | KIT | 1.90660042 |
| 14 | TYK2 | 1.80599740 |
| 15 | MAP3K5 | 1.76760262 |
| 16 | BLK | 1.76647251 |
| 17 | CCNB1 | 1.73650886 |
| 18 | MAP3K11 | 1.69159152 |
| 19 | FLT3 | 1.67123757 |
| 20 | IKBKE | 1.67003647 |
| 21 | BTK | 1.65824679 |
| 22 | TEC | 1.62282086 |
| 23 | ITK | 1.59975059 |
| 24 | IKBKB | 1.58904741 |
| 25 | CSK | 1.55041197 |
| 26 | CSF1R | 1.54732018 |
| 27 | VRK2 | 1.53130853 |
| 28 | ZAP70 | 1.51414125 |
| 29 | PIM2 | 1.43485970 |
| 30 | LCK | 1.42694117 |
| 31 | GRK7 | 1.30761293 |
| 32 | LYN | 1.30363576 |
| 33 | DAPK1 | 1.29948020 |
| 34 | PIM1 | 1.27299927 |
| 35 | JAK3 | 1.27111084 |
| 36 | TAOK1 | 1.23220246 |
| 37 | CDK8 | 1.19387554 |
| 38 | TNK2 | 1.18409281 |
| 39 | BMPR2 | 1.14336442 |
| 40 | MAP3K14 | 1.08910122 |
| 41 | RPS6KA4 | 1.08544161 |
| 42 | BRAF | 1.08022913 |
| 43 | IRAK4 | 1.02963065 |
| 44 | VRK1 | 0.96155833 |
| 45 | NUAK1 | 0.95769269 |
| 46 | GRK6 | 0.93070143 |
| 47 | HCK | 0.89348613 |
| 48 | DYRK3 | 0.88663167 |
| 49 | JAK2 | 0.86222172 |
| 50 | TAOK3 | 0.86083473 |
| 51 | ADRBK2 | 0.83287585 |
| 52 | EPHA4 | 0.78802271 |
| 53 | PRKCQ | 0.75421401 |
| 54 | ERN1 | 0.74879451 |
| 55 | ABL2 | 0.74598118 |
| 56 | MATK | 0.73852811 |
| 57 | TESK1 | 0.72141346 |
| 58 | MAPKAPK3 | 0.70869731 |
| 59 | JAK1 | 0.68545458 |
| 60 | RAF1 | 0.66477405 |
| 61 | PDK1 | 0.64942121 |
| 62 | IRAK2 | 0.63878119 |
| 63 | YES1 | 0.63683260 |
| 64 | MAPKAPK2 | 0.63288311 |
| 65 | RPS6KA5 | 0.62964538 |
| 66 | STK10 | 0.61460210 |
| 67 | SGK2 | 0.60838648 |
| 68 | MARK3 | 0.60836937 |
| 69 | TLK1 | 0.60270269 |
| 70 | FRK | 0.57220407 |
| 71 | PIK3CA | 0.56222385 |
| 72 | ARAF | 0.50774097 |
| 73 | ABL1 | 0.49556193 |
| 74 | RPS6KC1 | 0.47728108 |
| 75 | RPS6KL1 | 0.47728108 |
| 76 | DYRK1B | 0.47684647 |
| 77 | RPS6KA6 | 0.46777367 |
| 78 | MAPKAPK5 | 0.46137429 |
| 79 | MAP2K3 | 0.45928653 |
| 80 | HIPK2 | 0.45740559 |
| 81 | MAPK4 | 0.45426476 |
| 82 | CDK19 | 0.45262812 |
| 83 | MAPK13 | 0.44537883 |
| 84 | FGR | 0.44033193 |
| 85 | TAOK2 | 0.44015352 |
| 86 | IGF1R | 0.43969589 |
| 87 | MAP3K12 | 0.41219203 |
| 88 | MAPK3 | 0.39890510 |
| 89 | IRAK1 | 0.37031649 |
| 90 | IRAK3 | 0.36520762 |
| 91 | GRK1 | 0.35023521 |
| 92 | FYN | 0.33676461 |
| 93 | PRKD1 | 0.33478507 |
| 94 | BRD4 | 0.33339187 |
| 95 | DMPK | 0.30798451 |
| 96 | CHUK | 0.29771862 |
| 97 | ICK | 0.28090975 |
| 98 | PAK1 | 0.27847727 |
| 99 | EGFR | 0.27477422 |
| 100 | MAP4K2 | 0.25445608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 4.39650621 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 4.31034724 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.24676477 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.20274991 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.78590656 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.39146859 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.30504771 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.75984079 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.66702290 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 2.64226569 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.57552791 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.51650914 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.24171027 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.04299242 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.99968715 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.61792638 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55014630 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46108018 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.39161966 |
| 20 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.37549005 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.37023360 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.32320242 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30815590 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.30301993 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24598143 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.23003075 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.21749905 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.20072792 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.19645011 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.17388615 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.11385026 |
| 32 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.09476832 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09405462 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.09138334 |
| 35 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04250718 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.04198868 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.03154454 |
| 38 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.02972345 |
| 39 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.97410580 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95676573 |
| 41 | Malaria_Homo sapiens_hsa05144 | 0.93277800 |
| 42 | RNA polymerase_Homo sapiens_hsa03020 | 0.91861221 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86787212 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86252429 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 0.85357041 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83097575 |
| 47 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.77821158 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74562136 |
| 49 | Parkinsons disease_Homo sapiens_hsa05012 | 0.73349965 |
| 50 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.72642108 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68132919 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67077600 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64389041 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64003021 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63727888 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63222242 |
| 57 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61296991 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58456246 |
| 59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56290950 |
| 60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56092436 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52665046 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.50378004 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47937847 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46105875 |
| 65 | Proteasome_Homo sapiens_hsa03050 | 0.45869119 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.44930764 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.42055190 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.41890158 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41120046 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.40710940 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39159011 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.36795914 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35132019 |
| 74 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.34910805 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.25672787 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.24952066 |
| 77 | Homologous recombination_Homo sapiens_hsa03440 | 0.24281435 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.23564297 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23374800 |
| 80 | Spliceosome_Homo sapiens_hsa03040 | 0.22588738 |
| 81 | Olfactory transduction_Homo sapiens_hsa04740 | 0.22557239 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21195110 |
| 83 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.19767827 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.17938702 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.16446983 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.15955034 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.15450629 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.14614646 |
| 89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.13166352 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.13144118 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.12279514 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.11831557 |
| 93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.11117706 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.10396297 |
| 95 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.10192858 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09509466 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.08472783 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.08246041 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06442498 |
| 100 | RNA degradation_Homo sapiens_hsa03018 | 0.06236735 |

